ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

Epstein Hits NCI On Doll, Peto Reports, Greenwald Responds

July 3, 1992

ICCCR Loses Support Of French, DeVita Resigns As President, Fischinger To Take Over

July 17, 1992

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

March 31, 1995